With the dynamic range of the tau PET signal, it will be possible to identify more precise stages of AD beyond cognitively unimpaired, MCI, and AD, as proposed in the updated National Institute on Aging and Alzheimer’s Association (NIA-AA) biological staging framework [69]. The gene discussed is MAPT; the disease is Alzheimer disease.